Percheron Therapeutics Management
Management criteria checks 1/4
Percheron Therapeutics' CEO is James Garner, appointed in Aug 2023, has a tenure of 1.25 years. total yearly compensation is A$824.68K, comprised of 52.7% salary and 47.3% bonuses, including company stock and options. directly owns 0.13% of the company’s shares, worth A$101.75K. The average tenure of the management team and the board of directors is 1.3 years and 3.1 years respectively.
Key information
James Garner
Chief executive officer
AU$824.7k
Total compensation
| CEO salary percentage | 52.7% |
| CEO tenure | 1.3yrs |
| CEO ownership | 0.1% |
| Management average tenure | 1.3yrs |
| Board average tenure | 3.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | AU$825k | AU$434k | -AU$12m |
| Mar 31 2024 | n/a | n/a | -AU$11m |
| Dec 31 2023 | n/a | n/a | -AU$11m |
| Sep 30 2023 | n/a | n/a | -AU$11m |
| Jun 30 2023 | AU$34k | n/a | -AU$11m |
Compensation vs Market: James's total compensation ($USD535.93K) is above average for companies of similar size in the Australian market ($USD297.98K).
Compensation vs Earnings: James's compensation has increased whilst the company is unprofitable.
CEO
James Garner (51 yo)
1.3yrs
Tenure
AU$824,684
Compensation
Dr. James Garner, MA, MBA, MBBS, BSC (Hons), MAICD, serves as Non-Executive Director at Percheron Therapeutics Limited (formerly known as Antisense Therapeutics Limited) since May 08, 2023 and has been its...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Director | 1.3yrs | AU$824.68k | 0.13% A$ 101.7k | |
| Company Secretary & CFO | less than a year | AU$324.32k | no data | |
| Chief Operating Officer | 1.8yrs | AU$596.05k | no data | |
| Chief Medical Advisor | no data | no data | no data |
1.3yrs
Average Tenure
Experienced Management: PER's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Director | 1.5yrs | AU$824.68k | 0.13% A$ 101.7k | |
| Independent Non-Executive Director | 3.1yrs | AU$113.77k | 0.094% A$ 74.0k | |
| Independent Non-Executive Chair | 3.7yrs | AU$220.29k | 0.069% A$ 54.3k |
3.1yrs
Average Tenure
Experienced Board: PER's board of directors are considered experienced (3.1 years average tenure).